Ask AI
HERIZON GEA 01 PDL1 Subgroup Analysis
HERIZON-GEA-01: PD-L1 Subgroup Analysis From Phase III Trial of Zanidatamab + Chemotherapy ± Tislelizumab for First-line HER2+ Locally Advanced or Metastatic GEA

Released: June 16, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: June 16, 2026